Defibrotide Treatment for Hepatic Veno-occlusive Disease after Umbilical Cord Blood Transplantation / 대한소아혈액종양학회지
Korean Journal of Pediatric Hematology-Oncology
;
: 92-96, 2004.
Artículo
en Coreano
| WPRIM
| ID: wpr-114794
ABSTRACT
Veno-occlusive disease (VOD) of the liver is a life-threatening complication occurring early after blood or bone marrow transplantation (BMT). Effective treatment has not been established in case of severe forms of VOD. Defibrotide, a single-stranded polydeoxyribonucleotide, has been used on a compassionate basis in recent clinical trials with promising results. We report here with the first Korean experience of using defibrotide for the treatment of hepatic VOD occurring after unrelated umbilical cord blood transplant in a 2-year-old child with acute lymphoblastic leukemia. Defibrotide was administered for 23 days without any significant side effects with resolution of signs and symptoms of VOD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Cordón Umbilical
/
Enfermedad Veno-Oclusiva Hepática
/
Trasplante de Médula Ósea
/
Empatía
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Sangre Fetal
/
Hígado
Límite:
Niño
/
Child, preschool
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Pediatric Hematology-Oncology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS